RENVIVO Trademark

Trademark Overview


On Wednesday, December 2, 2015, a trademark application was filed for RENVIVO with the United States Patent and Trademark Office. The USPTO has given the RENVIVO trademark a serial number of 86837302. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2017. This trademark is owned by Global Medical & Research Technologies,Inc.. The RENVIVO trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Reagents, namely, a solution used for scientific and medical research purposes for handling of mammalian cells which keeps cells disaggregated, round and stopped in a stabile state while stabilizing membranes, membrane markers, membrane receptors and cluster differentiation (CD) markers; eukaryotic cell culture reagents, namely, a solution that contains enzymes for detaching and disassociating attached mammalian cell culture from the growth substrates for scientific research use or medical research use; Chemical preparations for scientific and medical research use, namely, sterile solutions that keeps dissociated eukaryotic cells round and unattached for long periods of time and blocks attachment to plastic surfaces for scientific and medical research purposes; chemical preparations for scientific and medical laboratory use, namely, a chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells, except for medical or veterinary...

Organ preservation solutions for medical transplant use, namely, storage and preservation solution for machine perfusion of animal and human organs, tissues, and cells, specifically kidneys, abdominal organs and tissues, thoracic organs and tissues, and stem cells, for the purpose of transplantation; Nutrient-based solutions for medical use to store and treat cells, tissues, and organs in order to sustain life-providing systems, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues, and organs while preventing or slowing their death; Organ preservation solutions for medical transplant use, namely, a static, hypothermic, flushing, transport, and storage solution for animal and human organs, tissues, and cells, specifically whole hearts, heart tissue, cardiomyocytes, and stem cells, for the purpose of transplantation; Organ preservation solutions for medical transp...
renvivo

General Information


Serial Number86837302
Word MarkRENVIVO
Filing DateWednesday, December 2, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements


Goods and ServicesReagents, namely, a solution used for scientific and medical research purposes for handling of mammalian cells which keeps cells disaggregated, round and stopped in a stabile state while stabilizing membranes, membrane markers, membrane receptors and cluster differentiation (CD) markers; eukaryotic cell culture reagents, namely, a solution that contains enzymes for detaching and disassociating attached mammalian cell culture from the growth substrates for scientific research use or medical research use; Chemical preparations for scientific and medical research use, namely, sterile solutions that keeps dissociated eukaryotic cells round and unattached for long periods of time and blocks attachment to plastic surfaces for scientific and medical research purposes; chemical preparations for scientific and medical laboratory use, namely, a chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells, except for medical or veterinary use
Goods and ServicesOrgan preservation solutions for medical transplant use, namely, storage and preservation solution for machine perfusion of animal and human organs, tissues, and cells, specifically kidneys, abdominal organs and tissues, thoracic organs and tissues, and stem cells, for the purpose of transplantation; Nutrient-based solutions for medical use to store and treat cells, tissues, and organs in order to sustain life-providing systems, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues, and organs while preventing or slowing their death; Organ preservation solutions for medical transplant use, namely, a static, hypothermic, flushing, transport, and storage solution for animal and human organs, tissues, and cells, specifically whole hearts, heart tissue, cardiomyocytes, and stem cells, for the purpose of transplantation; Organ preservation solutions for medical transplant use, namely, storage and preservation solution for donor animal tissues and organs for the purpose of transplantation and for use in long-term mesothermic machine perfusion and ex-vivo healing and repair of tissues and organs; cell culture media for medical and veterinary use, namely, protein-free media for growing cells in biomedical and mammalian cell culture applications; Nutrient-based solutions for medical use in applications which require the support of life-providing systems in cells, tissues and organs, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues and organs while preventing or slowing their death; Nutritive substances for microorganism cultures for medical use, namely, a production boosting chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells; Medical transplant solutions, namely, cornea preservation solutions used to aid in the flushing, transporting, storing, and preserving of animal corneas, eye tissues, eye cells, and stem cells for medical transplants
Translation of Words in MarkThe wording "RENVIVO" has no meaning in a foreign language.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2015
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlobal Medical & Research Technologies,Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Party NameGlobal Medical & Research Technologies,Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Trademark Events


Event DateEvent Description
Monday, March 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 16, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 6, 2016EXAMINER'S AMENDMENT ENTERED
Friday, May 6, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 6, 2016EXAMINERS AMENDMENT E-MAILED
Friday, May 6, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, April 18, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 18, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 8, 2016ASSIGNED TO LIE
Monday, March 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2016NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2016NON-FINAL ACTION WRITTEN
Monday, March 21, 2016ASSIGNED TO EXAMINER
Tuesday, December 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 5, 2015NEW APPLICATION ENTERED IN TRAM